Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Feasibility of circulating tumor DNA analysis in dogs with naturally occurring malignant and benign splenic lesions.

Scientific reports - 15 Apr 2022

Favaro Patricia Filippsen, Stewart Samuel D, McDonald Bradon R, Cawley Jacob, Contente-Cuomo Tania, Wong Shukmei, Hendricks William P D, Trent Jeffrey M, Khanna Chand, Murtaza Muhammed

Abstract excerpt

Comparative studies of naturally occurring canine cancers have provided new insight into many areas of cancer research. Development and validation of circulating tumor DNA (ctDNA) analysis in pet dogs can help address diagnostic needs in veterinary as well as human oncology. Dogs have high incidence of naturally occurring spontaneous cancers, demonstrate molecular heterogeneity and clonal evolution during...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Circulating Tumor DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Feasibility Studies

Share to Hemangiosarcoma

Share to Mutation

Share to Splenic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 35428782
DOI: 10.1038/s41598-022-09716-6
PMCID: PMC9012871

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Feasibility of circulating tumor DNA analysis in dogs with naturally occurring malignant and benign splenic lesions.PMID 35428782Read ↗

Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patientsSemantic proximity Read ↗

Identification of genomic alterations with clinical impact in canine splenic hemangiosarcomaSemantic proximity Read ↗

Horizons in Veterinary Precision Oncology: Fundamentals of Cancer Genomics and Applications of Liquid Biopsy for the Detection, Characterization, and Management of Cancer in DogsSemantic proximity Read ↗

Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients.Semantic proximity Read ↗

Whole Genome 3D Blood Biopsy Profiling of Canine Cancers: Development and Validation of EpiSwitch Multi-Choice Array-Based Diagnostic TestSemantic proximity Read ↗

Identification of genomic alterations with clinical impact in canine splenic hemangiosarcomaSemantic proximity Read ↗

Blood-Based Liquid Biopsy for Comprehensive Cancer Genomic Profiling Using Next-Generation Sequencing: An Emerging Paradigm for Non-invasive Cancer Detection and Management in DogsSemantic proximity Read ↗

Blood-based liquid biopsy for comprehensive cancer genomic profiling using next-generation sequencing: an emerging paradigm for noninvasive cancer detection and management in dogsSemantic proximity Read ↗

Real-world evidence couples genomic biomarkers with therapeutic outcomes for canine hemangiosarcomaSemantic proximity Read ↗

LINE-1 Methylation Status in Canine Splenic Hemangiosarcoma Tissue and Cell-Free DNASemantic proximity Read ↗

Leading the pack: Best practices in comparative canine cancer genomics to inform human oncologySemantic proximity Read ↗

Bringing the Genomic Revolution to Comparative Oncology: Human and Dog CancersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.